2023. Bioactive Secondary Metabolites to Combat Diabetic Complications: Evidenced from in Silico Study. Bangladesh Pharmaceutical Journal. 26, 2 (Aug. 2023), 167–184. DOI:https://doi.org/10.3329/bpj.v26i2.67807.